Literature DB >> 10595836

Radioiodine and thyroid-associated ophthalmopathy: from the myth to the reality.

C Beckers1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10595836     DOI： 10.1007/BF03343634

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  15 in total

1.  Radioiodine is an effective, inexpensive, and safe treatment for Graves' hyperthyroidism, its immunological effects must be taken into account.

Authors:  L Chiovato; R Rocchi; E Fiore
Journal:  J Endocrinol Invest       Date:  1999-04       Impact factor: 4.256

Review 2.  Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism.

Authors:  C Marcocci; L Bartalena; F Bogazzi; G Bruno-Bossio; A Pinchera
Journal:  Thyroid       Date:  1992       Impact factor: 6.568

3.  Therapeutic controversies. Retro-orbital radiation and radioactive iodide ablation of the thyroid may be good for Graves' ophthalmopathy.

Authors:  L J DeGroot; C A Gorman; A Pinchera; L Bartalena; C Marcocci; W M Wiersinga; M F Prummel; L Wartofsky; C ] Marocci C [corrected to Marcocci
Journal:  J Clin Endocrinol Metab       Date:  1995-02       Impact factor: 5.958

4.  Effect of subtotal thyroidectomy on natural history of ophthalmopathy in Graves' disease.

Authors:  Y Abe; H Sato; M Noguchi; T Mimura; K Sugino; O Ozaki; H Yoshimura; K Ito
Journal:  World J Surg       Date:  1998-07       Impact factor: 3.352

5.  Malignant ophthalmopathy presenting one week after radioiodine treatment of hyperthyroidism.

Authors:  L A Burmeister; R L Beatty; J R Wall
Journal:  Thyroid       Date:  1999-02       Impact factor: 6.568

Review 6.  Retro-orbital autoimmunity.

Authors:  A E Heufelder
Journal:  Baillieres Clin Endocrinol Metab       Date:  1997-10

7.  Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.

Authors:  L Bartalena; C Marcocci; F Bogazzi; L Manetti; M L Tanda; E Dell'Unto; G Bruno-Bossio; M Nardi; M P Bartolomei; A Lepri; G Rossi; E Martino; A Pinchera
Journal:  N Engl J Med       Date:  1998-01-08       Impact factor: 91.245

8.  Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic.

Authors:  P Perros; A L Crombie; J N Matthews; P Kendall-Taylor
Journal:  Clin Endocrinol (Oxf)       Date:  1993-04       Impact factor: 3.478

9.  Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves' disease.

Authors:  U Feldt-Rasmussen; H Schleusener; P Carayon
Journal:  J Clin Endocrinol Metab       Date:  1994-01       Impact factor: 5.958

10.  Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group.

Authors:  L Tallstedt; G Lundell; O Tørring; G Wallin; J G Ljunggren; H Blomgren; A Taube
Journal:  N Engl J Med       Date:  1992-06-25       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.